Lenskart shares rose on their second trading day after a volatile debut, leaving investors debating whether to buy, sell, or hold. Despite strong listing recovery and robust revenue growth, brokerages like Ambit Capital have turned cautious, citing steep valuations, thin margins, and delayed free cash flow visibility until FY28.